drug
bosakitug
Phase 2updated 6mo agoby $ACRS Aclaris Therapeutics, Inc.
Phase 2community read0 votes
all catalysts(0)
nothing on the calendar yet
News(1)
- Aclaris drops TSLP program from pipeline after flunking phase 2 eczema testA phase 2 study of Aclaris Therapeutics’ bosakitug in atopic dermatitis has missed its primary endpoint, adding to the setbacks anti-TSLP antibodies have encountered in the indication.fiercebiotech · 1d ago
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that